A new, nano-scale look at how the SARS-CoV-2 virus replicates in cells may offer greater precision in drug development, a Stanford University team reports in Nature Communications. Using advanced ...

The global pandemic may be over, but SARS-CoV-2 continues to infect people around the world. Indeed, the United States has recorded roughly 750 deaths from COVID-19 over the past month. Now, an siRNA ...

In a recent study published in the Journal of Experimental Medicine, researchers identified the cellular tropism and transcriptome consequences of severe acute respiratory syndrome coronavirus 2 (SARS ...

Two of the closest known relatives to SARS-CoV-2 — a pair of bat coronaviruses discovered by researchers in Laos — may transmit poorly in people despite being genetically similar to the ...

Forget about locating molecules in the blink of an eye, which takes as long as a quarter second—far too long a time to distinguish a sequence of subcellular events. Instead, try doing what Stanford ...

The question of the origin of SARS-CoV-2 continues to occupy scientists, the media, and the public intensely even 5 years after the onset of the COVID-19 pandemic. Where the virus came from, when and ...

Six years after the COVID-19 pandemic, which had claimed over 7 million lives worldwide by April 2024 (figures are no longer being tracked), we are still debating the origins of this novel virus. The ...

UCSF researchers designed new drug candidates that potently block MPro, a viral enzyme that's crucial for SARS-CoV-2 replication. One of these drug candidates, AVI-4516, is shown (center) bound to the ...

Two of the closest known relatives to SARS-CoV-2 -- a pair of bat coronaviruses discovered by researchers in Laos -- may transmit poorly in people despite being genetically similar to the ...